Search - tctmd.com

Displaying 1 - 20 of 409

Sort: Relevancy | Date

Presentation THT 2026

Advances in Afib Ablation Strategies: What Does the HF Doctor Need To Know?

Presenter: Hirad Yarmohammadi

March 03, 2026

Presentation THT 2026

Managing Afib: Is There a Difference in HFpEF vs HFrEF

Presenter: Nassir F. Marrouche

March 03, 2026

Presentation THT 2026

Wearables for Afib Detection — What is the Threshold for Intervention?

Presenter: Kola Agboola

March 03, 2026

Presentation THT 2026

Managing Persistent Atrial Fibrillation in HF: Medications vs AV Node Ablation/Pacing vs AF Ablation

Presenter: Andrea Russo

March 03, 2026

Presentation THT 2026

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mark Darkwah

March 03, 2026

Presentation THT Abstracts 2026

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation

Presenter: Mark Darkwah

March 02, 2026

Presentation THT Abstracts 2026

CARDIAC RECOVERY AFTER ABLATION FOR ATRIAL FIBRILLATION

Presenter: Jaclyn Hayma

March 02, 2026

Presentation THT Abstracts 2026

Risk of Recurrence After Atrial Fibrillation Catheter Ablation in Heart Failure with Preserved Vs Reduced Ejection Fraction

Presenter: Nishanth Katukuri

March 02, 2026

Presentation TCT 2025

TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation

Presenter: Kuseme Udoh

October 28, 2025

Presentation TCT 2025

TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis

Presenter: Adham Ramadan

October 28, 2025

Presentation TCT 2025

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

Presenter: Muhammad Zahid

October 28, 2025

Presentation TCT 2025

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Thomas E. Waggoner

October 28, 2025

Presentation TCT 2025

TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention

Presenter: Khaled Elnaggar

October 28, 2025

Presentation TCT 2025

TCT 738: Percutaneous LAA closure in patients with non-valvular atrial fibrillation and cancer

Presenter: Carlos Eduardo Vergara Uzcategui

October 28, 2025

Presentation TCT 2025

TCT 742: Risks of Major Bleeding and Hospitalization for Falls After Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and History of Falls: A Propensity-Matched Analysis

Presenter: Mohamed Doma

October 28, 2025

Presentation TCT 2025

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

Presenter: Devi G. Nair

October 28, 2025

Presentation TCT 2025

TCT 733: CHA2DS2-VASc Score As a Predictor for Outcomes Following Left Atrial Appendage Closure Devices in Non-valvular Atrial Fibrillation; A Retrospective Analysis

Presenter: Joud Fahed

October 28, 2025

Presentation TCT 2025

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

Presenter: Zeyad Kholeif

October 27, 2025

Presentation TCT 2025

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

Presenter: Mehmet Cilingiroglu

October 27, 2025

Advertisement

Advances in Afib Ablation Strategies: What Does the HF Doctor Need To Know?

Managing Afib: Is There a Difference in HFpEF vs HFrEF

Wearables for Afib Detection — What is the Threshold for Intervention?

Managing Persistent Atrial Fibrillation in HF: Medications vs AV Node Ablation/Pacing vs AF Ablation

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation

CARDIAC RECOVERY AFTER ABLATION FOR ATRIAL FIBRILLATION

Risk of Recurrence After Atrial Fibrillation Catheter Ablation in Heart Failure with Preserved Vs Reduced Ejection Fraction

TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction

TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation

TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention

TCT 738: Percutaneous LAA closure in patients with non-valvular atrial fibrillation and cancer

TCT 742: Risks of Major Bleeding and Hospitalization for Falls After Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and History of Falls: A Propensity-Matched Analysis

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

TCT 733: CHA2DS2-VASc Score As a Predictor for Outcomes Following Left Atrial Appendage Closure Devices in Non-valvular Atrial Fibrillation; A Retrospective Analysis

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content